Total Payments
$29,309
2024 Payments
$513.69
Companies
20
Transactions
63
Medicare Patients
1,369
Medicare Billing
$365,097
Payment Breakdown by Category
Research$24,150 (82.4%)
Food & Beverage$4,584 (15.6%)
Other$540.00 (1.8%)
Consulting$35.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $24,150 | 1 | 82.4% |
| Food and Beverage | $4,584 | 47 | 15.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $540.00 | 14 | 1.8% |
| Consulting Fee | $35.00 | 1 | 0.1% |
Payments by Type
Research
$24,150
1 transactions
General
$5,159
62 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $24,268 | 2 | $0 (2022) |
| AbbVie Inc. | $1,958 | 16 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $540.00 | 14 | $0 (2017) |
| Amgen Inc. | $495.59 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $263.91 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $246.41 | 4 | $0 (2021) |
| Lilly USA, LLC | $245.36 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $175.41 | 5 | $0 (2022) |
| Mylan Specialty L.P. | $147.76 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $131.12 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $513.69 | 4 | Janssen Biotech, Inc. ($263.91) |
| 2023 | $254.90 | 3 | Amgen Inc. ($120.59) |
| 2022 | $25,359 | 12 | Novartis Pharmaceuticals Corporation ($24,150) |
| 2021 | $541.07 | 9 | AbbVie Inc. ($250.52) |
| 2020 | $144.45 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($97.76) |
| 2019 | $1,133 | 10 | Amgen Inc. ($375.00) |
| 2018 | $466.92 | 4 | AbbVie, Inc. ($342.15) |
| 2017 | $895.53 | 17 | SANOFI-AVENTIS U.S. LLC ($540.00) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $124.77 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $133.91 | General |
| Category: Immunology | ||||||
| 01/11/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: Immunology | ||||||
| 08/23/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $99.31 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $120.59 | General |
| Category: Bone Health | ||||||
| 01/29/2023 | Medtronic, Inc. | MEROCEL (Device) | Consulting Fee | Cash or cash equivalent | $35.00 | General |
| Category: Dressing, stents and packing | ||||||
| 11/28/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $120.59 | General |
| Category: Immunology | ||||||
| 09/07/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: KRYSTEXXA | ||||||
| 08/18/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $123.04 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/01/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/05/2022 | Novartis Pharmaceuticals Corporation | — | — | In-kind items and services | $24,150.00 | Research |
| Study: PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH HEOR RESEARCH | ||||||
| 05/18/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $118.99 | General |
| Category: IMMUNOLOGY | ||||||
| 03/30/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $174.99 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $119.91 | General |
| Category: Cardiovascular | ||||||
| 01/18/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: DIABETES | ||||||
| 01/12/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $119.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/21/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $110.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| Category: Cardiovascular | ||||||
| 08/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $104.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/16/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/20/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.51 | General |
| Category: Cardiovascular | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PUBLICATION SUPPORT PROVIDED IN CONNECTION WITH HEOR RESEARCH | Novartis Pharmaceuticals Corporation | $24,150 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 189 | 485 | $134,811 | $39,286 |
| 2022 | 6 | 401 | 1,539 | $436,727 | $118,162 |
| 2021 | 4 | 382 | 1,464 | $367,087 | $104,539 |
| 2020 | 5 | 397 | 1,359 | $387,216 | $103,110 |
Total Patients
1,369
Total Services
4,847
Medicare Billing
$365,097
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 213 | $54,658 | $15,547 | 28.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 54 | $16,254 | $5,956 | 36.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 48 | $19,152 | $5,677 | 29.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 109 | $18,857 | $5,143 | 27.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $14,184 | $3,887 | 27.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 18 | 19 | $6,720 | $1,715 | 25.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 18 | $4,986 | $1,362 | 27.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 130 | 1,065 | $260,925 | $70,303 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 38 | 236 | $82,836 | $22,616 | 27.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 86 | 88 | $41,272 | $11,139 | 27.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 92 | 94 | $23,218 | $6,311 | 27.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $17,706 | $4,846 | 27.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 29 | 30 | $10,770 | $2,947 | 27.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 140 | 1,207 | $286,059 | $81,845 | 28.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 98 | 102 | $46,206 | $12,838 | 27.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 107 | 114 | $27,360 | $7,876 | 28.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 37 | 41 | $7,462 | $1,980 | 26.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 122 | 1,076 | $274,380 | $73,535 | 26.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 90 | 90 | $64,530 | $16,715 | 25.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 109 | 114 | $29,526 | $7,956 | 26.9% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 64 | 67 | $12,864 | $3,303 | 25.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $5,916 | $1,601 | 27.1% |
About Dr. Jun Zhang, MD
Dr. Jun Zhang, MD is a Physical Medicine & Rehabilitation healthcare provider based in Jamaica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902000953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jun Zhang, MD has received a total of $29,309 in payments from pharmaceutical and medical device companies, with $513.69 received in 2024. These payments were reported across 63 transactions from 20 companies. The most common payment nature is "" ($24,150).
As a Medicare-enrolled provider, Zhang has provided services to 1,369 Medicare beneficiaries, totaling 4,847 services with total Medicare billing of $365,097. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Jamaica, NY
- Active Since 06/13/2007
- Last Updated 03/05/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1902000953
Products in Payments
- RINVOQ (Biological) $1,012
- SYNVISC-ONE (Device) $540.00
- Humira (Biological) $491.09
- Enbrel (Biological) $250.00
- XARELTO (Drug) $246.41
- EVENITY (Biological) $245.59
- TALTZ (Drug) $245.36
- ELIQUIS (Drug) $175.41
- Yupelri (Drug) $147.76
- TREMFYA (Drug) $133.91
- SIMPONI ARIA (Biological) $130.00
- Bimzelx (Biological) $125.01
- XELJANZ (Drug) $125.00
- KRYSTEXXA (Biological) $124.99
- Prolastin-C (Biological) $124.96
- Tymlos (Biological) $124.77
- XEOMIN (Biological) $124.77
- MEROCEL (Device) $35.00
- JARDIANCE (Drug) $33.36
- IFUSE IMPLANT (Device) $25.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Jamaica
Saroj Gupta, Md, MD
Physical Medicine & Rehabilitation — Payments: $2,938
Physical Medicine & Rehabilitation $2,938
Dr. Hasan Chughtai, Do, DO
Physical Medicine & Rehabilitation — Payments: $563.64
Physical Medicine & Rehabilitation $563.64
Peng Zhao, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $256.19
Physical Medicine & Rehabilitation $256.19
Dr. Jenny Lee, Md, MD
Physical Medicine & Rehabilitation — Payments: $119.40
Physical Medicine & Rehabilitation $119.40
Quasem Chowdhury, Md, MD
Physical Medicine & Rehabilitation — Payments: $103.78
Physical Medicine & Rehabilitation $103.78
Terry Mathew, Md, MD
Physical Medicine & Rehabilitation — Payments: $30.05
Physical Medicine & Rehabilitation $30.05